Immunity to cardiac autoantigens other than myosin have been identified in T. cruzi-infected humans and in animal models of CHD [5], [28], [29], [30], [31], [32], but a comprehensive study of this polyantigenic autoimmunity in a single model system has not been described. The gene discussed is MYH14; the disease is coronary artery disorder.